<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04364412</url>
  </required_header>
  <id_info>
    <org_study_id>70/2018</org_study_id>
    <nct_id>NCT04364412</nct_id>
  </id_info>
  <brief_title>Acute Lower gastroIntestinal BleedIng (ALIBI Study) in Italy</brief_title>
  <acronym>ALIBI</acronym>
  <official_title>Acute Lower gastroIntestinal BleedIng (ALIBI Study): a Multicentre Prospective, Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Valduce Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Valduce Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Unlike upper GI bleeding, for LGIB there is still a paucity of data on clinical presentation,
      patient characteristics, pathways of care and outcomes for LGIB patients. In-hospital
      mortality ranges from 1.2% to 8.8% (2-4), according to retrospective studies, but data from
      prospective series are still limited (5).

      Present multicentre, prospective, observational study was designed to explore these areas, to
      assess variations in practice management and to identify factors associated with patient
      outcomes.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 1, 2019</start_date>
  <completion_date type="Actual">May 18, 2020</completion_date>
  <primary_completion_date type="Actual">May 18, 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>15 Days</target_duration>
  <primary_outcome>
    <measure>Mortality rate in patients admitted for acute lower GI bleeding</measure>
    <time_frame>4 weeks</time_frame>
    <description>Number of deaths among the study cohort</description>
  </primary_outcome>
  <enrollment type="Actual">1198</enrollment>
  <condition>Lower GI Bleeding</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Consecutive, unselected outpatients acutely admitted for LGIB or developing LGIB during
        hospital stay (inpatients) were eligible for inclusion if they fulfilled the following
        criteria: i) age &gt; 18 years; ii) recent (&lt; 3 days) onset of overt bleeding with bright or
        dark blood or clots per rectum or melaena without hematemesis
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  adult patients with acute lower GI bleeding

        Exclusion Criteria:

          -  age below 18 years

          -  bleeding patients with an upper GI source
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Valduce Hospital</name>
      <address>
        <city>Como</city>
        <zip>22100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>April 6, 2020</study_first_submitted>
  <study_first_submitted_qc>April 26, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 28, 2020</study_first_posted>
  <last_update_submitted>May 18, 2020</last_update_submitted>
  <last_update_submitted_qc>May 18, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Valduce Hospital</investigator_affiliation>
    <investigator_full_name>Franco Radaelli</investigator_full_name>
    <investigator_title>Head of Gastroenterology Department</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastrointestinal Hemorrhage</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

